Type Public Founded 2002 | Website www.orexigen.com | |
 | ||
Stock price OREX (NASDAQ) US$ 3.98 -0.02 (-0.50%)24 Mar, 4:00 PM GMT-4 - Disclaimer Headquarters La Jolla, California, United States Founders Michael Cowley, John Francis Crowley, Eckard Weber | ||
orex orexigen therapeutics inc independent analysis
Orexigen Therapeutics is a public American pharmaceutical company focused on development of treatments for obesity. The company is based in La Jolla, California and was established by Eckard Weber in 2002. As a public company, Orexigen is traded on the NASDAQ exchange under the stock symbol OREX. The company has a single product, Contrave, approved for use in the United States in 2014. The launch of Contrave was conducted through a sales force of 900. Observation of the market performance of Qsymia and Belviq suggest overall low demand for pharmaceutical obesity therapies, calling into question earnings potential for Orexigen's offering.
Contents
News update shares of orexigen therapeutics inc orex plummet
References
Orexigen Therapeutics Wikipedia(Text) CC BY-SA